383 related articles for article (PubMed ID: 17646097)
21. Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas.
Massart F; Becherini L; Marini F; Noci I; Piciocchi L; Del Monte F; Masi L; Falchetti A; Tanini A; Scarselli G; Brandi L
Med Sci Monit; 2003 Jan; 9(1):BR25-30. PubMed ID: 12552233
[TBL] [Abstract][Full Text] [Related]
22. Assessment of morphological changes and steroid receptors in the uteri of postmenopausal women.
Teresiński L; Sipak O; Rył A; Masiuk M; Rotter I; Ratajczak W; Łazowska M; Słomczyńska M; Marchlewicz M; Karakiewicz B; Kram A; Laszczyńska M
Histol Histopathol; 2019 Jun; 34(6):631-644. PubMed ID: 30426467
[TBL] [Abstract][Full Text] [Related]
23. Differentially regulated expression of neurokinin B (NKB)/NK3 receptor system in uterine leiomyomata.
Cañete H; Dorta I; Hernández M; Cejudo Roman A; Candenas L; Pinto FM; Valladares F; Báez D; Montes de Oca F; Bello AR; Almeida TA
Hum Reprod; 2013 Jul; 28(7):1799-808. PubMed ID: 23656837
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen and progesterone receptor concentrations in leiomyoma and normal myometrium.
Sadan O; van Iddekinge B; van Gelderen CJ; Savage N; Becker PJ; van der Walt LA; Robinson M
Ann Clin Biochem; 1987 May; 24 ( Pt 3)():263-7. PubMed ID: 3606010
[TBL] [Abstract][Full Text] [Related]
25. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium.
Lessl M; Klotzbuecher M; Schoen S; Reles A; Stöckemann K; Fuhrmann U
J Clin Endocrinol Metab; 1997 Aug; 82(8):2596-600. PubMed ID: 9253340
[TBL] [Abstract][Full Text] [Related]
26. Are there any differences in the expression of hormonal receptors and proliferation markers between uterine and extrauterine leiomyomas?
Sen N; Demirkan NC; Colakoglu N; Duzcan SE
Int J Surg Pathol; 2008 Jan; 16(1):43-7. PubMed ID: 18203783
[TBL] [Abstract][Full Text] [Related]
27. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S; Asano R; Wakabayashi R; Hayashi H; Shigeta H
BMC Womens Health; 2022 Aug; 22(1):346. PubMed ID: 35974345
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
Sharara FI; Nieman LK
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
[TBL] [Abstract][Full Text] [Related]
29. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
30. Growth factors and cytokines in uterine leiomyomas.
Andersen J
Semin Reprod Endocrinol; 1996 Aug; 14(3):269-82. PubMed ID: 8885057
[TBL] [Abstract][Full Text] [Related]
31. Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.
Veronica M; Ali A; Venkateshwari A; Mamata D; Nallari P
Tumour Biol; 2016 Jun; 37(6):8067-74. PubMed ID: 26715264
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor gene expression in human uterine leiomyomata.
Brandon DD; Erickson TE; Keenan EJ; Strawn EY; Novy MJ; Burry KA; Warner C; Clinton GM
J Clin Endocrinol Metab; 1995 Jun; 80(6):1876-81. PubMed ID: 7775635
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation and gene hypermethylation of the 14-3-3 gamma in uterine leiomyoma.
Jiang W; Luo H; Shen Z; Zhang W; Chen A; Zhu X
Front Biosci (Landmark Ed); 2016 Jun; 21(6):1286-95. PubMed ID: 27100507
[TBL] [Abstract][Full Text] [Related]
35. [The analysis of estrogen and pregesterone receptors in leiomyomas cell in different phases of menstrual cycle].
Zasławski R; Surowiak P; Pratnik L; Dziegiel P; Zabel M
Ginekol Pol; 2000 Apr; 71(4):375-80. PubMed ID: 10860276
[TBL] [Abstract][Full Text] [Related]
36. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.
Stewart EA; Friedman AJ; Peck K; Nowak RA
J Clin Endocrinol Metab; 1994 Sep; 79(3):900-6. PubMed ID: 8077380
[TBL] [Abstract][Full Text] [Related]
37. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women.
Christian RC; Liu PY; Harrington S; Ruan M; Miller VM; Fitzpatrick LA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2713-20. PubMed ID: 16608893
[TBL] [Abstract][Full Text] [Related]
38. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
Zhang ZL; Zhang Y; Xu BQ
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
[TBL] [Abstract][Full Text] [Related]
39. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism.
Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M
Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242
[TBL] [Abstract][Full Text] [Related]
40. [Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues].
Wang SY; Xue Q; Zhou YF; Yin L
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):249-254. PubMed ID: 31006191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
